An Open-Label, Randomized, 2-Way Crossover Study to Evaluate the Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Omega-3 carboxylic acids (Primary) ; Aspirin; Simvastatin
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Omthera Pharmaceuticals
- 14 Feb 2017 Results of this and another phase I trial (NCT01431690) published in the American Journal of Cardiovascular Drugs.
- 27 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.